← SynDRA
PIRETANIDE
SynDRA canonical compound SYN0005156 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | SLC12A2 |
|---|
| Mechanism of action | Glucocorticoid receptor agonist |
|---|
| Indication | edema | hypertension |
|---|
| Disease area | cardiology |
|---|
All known targets
Mechanisms of action (all sources)
- NR3C1 AGONIST
- SLC12A2 INHIBITOR
- SLC12A1 INHIBITOR
- SLC12A1 BLOCKER
Drug classes
- Diuretics
- Membrane Transport Modulators
- Natriuretic Agents
- Sodium Potassium Chloride Symporter Inhibitors
ATC classes
- C03C · HIGH-CEILING DIURETICS
Cross-references
Synonyms
- arelix
- diumax
- eurelix
- Piretanida
- HOE-118
- S-73-4118
- S-734118
- Arelix
- Tauliz
- Arlix
- 4-phenoxy-3-(pyrrolidin-1-yl)-5-sulfamoylbenzoic acid
- Piretanido [Spanish]
- Hoe-118
- Piretanidum [INN-Latin]
- Piretanido [INN-Spanish]
- UNII-DQ6KK6GV93
- Arelix (TN)
- C17H18N2O5S
- EINECS 259-852-9
- BRN 5633965
- DQ6KK6GV93
- 4-phenoxy-3-pyrrolidin-1-yl-5-sulfamoylbenzoic acid
- 4-Phenoxy-3-(1-pyrrolidinyl)-5-sulfamoylbenzoic acid
- S 734118
- S 73 4118
- NCGC00016878-01
- 3-(Aminosulfonyl)-4-phenoxy-5-(1-pyrrolidinyl)-benzoic acid
- Benzoic acid, 3-(aminosulfonyl)-4-phenoxy-5-(1-pyrrolidin
- Eurelix
- Benzoic acid, 3-(aminosulfonyl)-4-phenoxy-5-(1-pyrrolidinyl)-
- CAS-55837-27-9
- Piretanido
- Piretanidum
- Piretanide [USAN:INN:BAN:JAN]
- Piretanide-[d4]
- PIRETANIDE [MI]
- PIRETANIDE [INN]
- PIRETANIDE [JAN]
Look up PIRETANIDE in the interactive SynDRA portal →